|
Reactogenicity and Immunogenicity of the pentavalent vaccine DPT-HB+Hib. Schedule 6-10-14 weeks. |
|
Early use of surfacen in the respiratory distress syndrome of the newborn. Phase IV |
|
Phase I/II clinical trial for the evaluation of vaccine candidate CIGB-230 in patients with chronic renal insufficiency. |
|
Efficacy of the Glicigen – Viusid in the treatment of external genitals anus wart in children |
|
Effect and Safety of ior® EPOCIM in patients with Non-Hodking Lymphoma treated with anthracyclines. |
|
Mebendazole compared with secnidazole-adult giardiasis-Phase III |
|
Lidoment - pain osteomioarticular - phase IV |
|
THERESA-3 Study |
|
EPOCIM in benign prostatic hyperplasia. |
|
Cicatrix Cream in post surgical scarps and epidermic burn |
|
Cicatrix Cream in cutaneous striae |
|
Nimotuzumab- Head and neck cancer |
|
Effectiveness and safety of ior EPOCIM in anemia in premature infant. |
|
Effectiveness and Safety of Nimotuzumab for the treatment of patients with glioma tumors |
|
Zinc Supplement in ill persons with ataxia type SCA-2. |
|
Effectiveness and Safety of use ior LeukoCIM as prophylaxis and treatment of Neutropenia in patients with HIV / AIDS. |
|
Impact of the Granulocytes Colony-Stimulating Factor (ior-LeukoCIM) in primary and secondary prophylaxis and post chemotherapy and/or radiotherapy neutropenia in oncohematological pediatric patients. |
|
Safety assessment of Granulocyte Colony Stimulating Factor:ior LeukoCIM in oncohematologic patients.Phase IV study. |
|
Effectiveness and Safety of ior EPOCIM in patients with Chronic Renal Failure on dialysis methods. |
|
Amniotic Membrane Transplantation vs Conjunctival–Limbal Autograft for Primary Pterygium |
